BALTIMORE, May 29, 2025 /PRNewswire/ — CraniUS Therapeutics, a cutting-edge medical device company advancing intracranial drug delivery, is proud to announce it has been voted the “2025 Emerging Life Sciences Company of the Year” by the Maryland Tech Council (MTC). The honor was presented during the Council’s prestigious Industry Awards Celebration, which drew over 600 attendees, and recognizes the state’s most innovative and impactful companies in technology and life sciences.

About CraniUS

About CraniUS™

CraniUS™ was founded May 2021 in Baltimore, MD, as a byproduct of the emerging field known as “Neuroplastic and Reconstructive Surgery”, through the vision, insight, and pioneering work of Dr. Chad Gordon. CraniUS™ has raised over $24M to date, been issued 7 patents, and is currently in the midst of a Series B raise.

The NeuroPASS™ device is currently in the pre-clinical development stage and is not yet commercially available. It is on the pathway to clinical studies, and any information provided is subject to change as research progresses.